In this context, advances in the comprehension of GBM molecular biology and genetic allowed the identification of the main alterations in cancer-related genes, including PDGFR, TP53, TERT and EGFR, and the involvement of aberrant networks regulated by non-coding RNAs (ncRNAs) [15,16]. This evidence concerns the gene PDGFRB and glioblastoma.